ScienceDaily (Mar. 26, 2012) A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neuron disease (MND). The international research team has created motor neurons using skin cells from a patient with an inherited form of MND.
A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neurone disease (MND). The international research team has created motor neurones using skin cells from a patient with an inherited form of MND.
An article published in the journal Proceedings of the National Academy of Sciences reports a breakthrough using cutting-edge stem cell research, which could speed up the discovery of new treatments for amyotrophic lateral sclerosis (ALS) also known as motor neuron disease (MND) outside the United States.Washington, D.C.
Public release date: 26-Mar-2012 [ | E-mail | Share ] Contact: Tara Womersley tara.womersley@ed.ac.uk 44-131-650-9836 University of Edinburgh A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neurone disease (MND). The international research team has created motor neurones using skin cells from a patient with an inherited form of MND.
NEW YORK–(BUSINESS WIRE)– Pfizer Oncology will present data from a variety of preclinical and clinical studies of Pfizers early-stage compounds, including data from Pfizers investigational antibody-drug conjugate (ADC) portfolio and research evaluating several molecules targeting novel pathways that play a crucial role in basic cellular functions, at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, IL, from March 31-April 4. The data we will present at AACR are representative of our continued commitment to emerging science and to advancing research and development in the area of antibody-drug conjugates, said Bob Abraham, PhD, senior vice president and chief scientific officer, Oncology Research Unit.
Public release date: 25-Mar-2012 [ | E-mail | Share ] Contact: Michael Bernstein m_bernstein@acs.org 619-525-6268 (March 23-28, San Diego Press Center) 202-872-6042 Michael Woods m_woods@acs.org 619-525-6268 (March 23-28, San Diego Press Center) 202-872-6293 American Chemical Society SAN DIEGO, March 25, 2012 Medicine’s recipe for keeping older people active and functioning in their homes and workplaces and healing younger people injured in catastrophic accidents may include “noodle gels” and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS). The world’s largest scientific society, ACS is meeting here this week with reports on more than 11,000 reports on new advances in science on its schedule
A local toddler with a very rare disease has begun a long recovery in Penn State Hershey Childrens Hospital after chemotherapy and a stem cell transplant. Chevy Hockenberry, the 23-month-old son of Lance Hockenberry and Melissa Johnson of Mercersburg, suffers from Hurlers syndrome, a rare inherited genetic disorder that if left untreated, causes death within five years. People with Hurlers syndrome do not produce lysosomal alpha-L-iduronidase, an enzyme that helps break down long chains of sugar molecules.
Public release date: 22-Mar-2012 [ | E-mail | Share ] Contact: Vanessa Wasta wasta@jhmi.edu 410-614-2916 Johns Hopkins Medical Institutions Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA
March 21, 2012|8:48 am Case in point: StemCells, Inc. just put out a news release for investors in which they announced their latest money-making opportunity using the brains from aborted babies for research. Of course they don’t call the brains “brains,” nor do they mention that the organs were part of a baby once residing safely in a mother’s womb
Can humans live without oxygen? Can the residents of Baguio do away with oxygen? We are forced to ask this question in view of the impending death of 182 trees at Luneta Hill of Baguio City which are meant to be cut or earth-balled any day now
A special dog used to help people is getting some much-needed help of her own at a Virginia clinic.
Huntington’s disease, the debilitating congenital neurological disorder that progressively robs patients of muscle coordination and cognitive ability, is a condition without effective treatment, a slow death sentence. But if researchers can build on new research reported this week (March 15, 2012) in the journal Cell Stem Cell, a special type of brain cell forged from stem cells could help restore the muscle coordination deficits that cause the uncontrollable spasms characteristic of the disease
Washington, Mar 16 (ANI): A special type of brain cell forged from stem cells could help restore the muscle coordination deficits that cause the uncontrollable spasms characteristic of Huntington’s disease, a new study has suggested. Huntington’s disease, the debilitating congenital neurological disorder that progressively robs patients of muscle coordination and cognitive ability, is a condition without effective treatment, a slow death sentence. “This is really something unexpected,” said Su-Chun Zhang, a University of Wisconsin-Madison neuroscientist and the senior author of the new study, which showed that locomotion could be restored in mice with a Huntington’s-like condition.
Public release date: 15-Mar-2012 [ | E-mail | Share ] Contact: Su-Chun Zhang zhang@waisman.wisc.edu 608-265-2543 University of Wisconsin-Madison MADISON — Huntington’s disease, the debilitating congenital neurological disorder that progressively robs patients of muscle coordination and cognitive ability, is a condition without effective treatment, a slow death sentence. But if researchers can build on new research reported this week (March 15, 2012) in the journal Cell Stem Cell, a special type of brain cell forged from stem cells could help restore the muscle coordination deficits that cause the uncontrollable spasms characteristic of the disease. “This is really something unexpected,” says Su-Chun Zhang, a University of Wisconsin-Madison neuroscientist and the senior author of the new study, which showed that locomotion could be restored in mice with a Huntington’s-like condition.
TEL AVIV, Israel–(BUSINESS WIRE)– Orgenesis Inc., (OTCBB: ORGS) (the Company) announced today that pursuant to a licensing agreement dated February 2, 2012 with Tel Hashomer – Medical Research, Infrastructure and Services Ltd. (“Tel Hashomer” or “THM), the Company has an exclusive license to develop and commercialize THM’s rights in functional autologous insulin producing cells (AIPC) regeneration technology. This licensed portfolio is based on the groundbreaking work and two decades of research by the world renowned researcher, Prof
Public release date: 12-Mar-2012 [ | E-mail | Share ] Contact: Kim Irwin kirwin@mednet.ucla.edu 310-206-2805 University of California – Los Angeles Health Sciences Researchers at the UCLA stem cell center and the departments of chemistry and biochemistry and pathology and laboratory medicine have identified, for the first time, a generic way to correct mutations in human mitochondrial DNA by targeting corrective RNAs, a finding with implications for treating a host of mitochondrial diseases.
BEIJING–(BUSINESS WIRE)– The Prostate Cancer Foundation today announced its first two Young Investigators in China to launch its initiative to identify, fund and promote innovative research projects within China. As with all of its funded research across the globe, the PCF China program carries the ultimate goal of ending death and suffering from prostate cancer. PCFs first two Young Investigators in China will be honored at a special awards dinner this evening following PCF Chinas First Annual Prostate Cancer Symposium being held today at Peking Universitys Wu Jieping Urology Center, 9:0015:00.
BONITA SPRINGS, FL – The state Surgeon General has issued an emergency suspension of the license of Dr. Zannos Grekos for providing a stem cell treatment to a patient contrary to previous restrictions placed on his license
Newswise CHICAGO, IL March 8, 2012 Stem cells provide a recurring topic among the scientific presentations at the Genetics Society of Americas 53rd Annual Drosophila Research Conference, March 7-11 at the Sheraton Chicago Hotel & Towers. Specifically, researchers are trying to determine how, within organs, cells specialize while stem cells maintain tissues and enable them to repair damage and respond to stress or aging. Four talks, one on Thursday morning and three on Sunday morning, present variations on this theme.
Public release date: 8-Mar-2012 [ | E-mail | Share ] Contact: Phyllis Edelman pedelman@genetics-gsa.org 301-351-0896 Genetics Society of America CHICAGO, IL March 8, 2012 Stem cells provide a recurring topic among the scientific presentations at the Genetics Society of America’s 53rd Annual Drosophila Research Conference, March 7-11 at the Sheraton Chicago Hotel & Towers. Specifically, researchers are trying to determine how, within organs, cells specialize while stem cells maintain tissues and enable them to repair damage and respond to stress or aging.